The Northern Hospital in Epping, Melbourne, Australia, is major community hospital. It lies in the north of Melbourne, next to Pacific Epping. It is a 400-bed hospital serving the northern suburbs of Melbourne, as well as the surrounding country areas of Victoria.

There are 400 beds in The Northern Hospital.

During the past decade, The Northern Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 14 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 9 clinical trials were completed. i.e. 52.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Northern Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Austin Health" with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Northern Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "The George Institute" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "The Northern Hospital" are "Coronary Artery Disease" (6 trials), "Heart Failure" (4 trials), "Cardiovascular Disease" (3 trials), "Acute Renal Failure" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "The Northern Hospital" in a lesser frequency.

Most popular intervention types in "The Northern Hospital" are "Drug" (30 trials), "Other" (10 trials), "Device" (9 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Empagliflozin" (2 trials), "Etrasimod" (2 trials), "Mirikizumab" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Northern Hospital" are 47 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "The Northern Hospital". undefined are not yet recruiting, 12 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in The Northern Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The Northern Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".